| Name | Title | Contact Details |
|---|
Biocartis is a molecular diagnostics company based in Mechelen, Belgium, founded in 2007. The company focuses on enhancing molecular testing through its proprietary Idylla TM Platform, which aims to make personalized medicine accessible by providing fast and convenient testing solutions suitable for various laboratory settings. Biocartis specializes in oncology diagnostics, offering a range of tests for cancers such as melanoma, colorectal, lung, brain, blood, and breast cancer. The Idylla Platform is a fully automated system that utilizes real-time PCR technology, enabling rapid in-house testing with results available in 30 to 150 minutes. In addition to oncology, Biocartis develops tests for infectious diseases, including panels for SARS-CoV-2, flu, and RSV, as well as the SeptiCyte RAPID test for host response. The company collaborates with major pharmaceutical and biotechnology firms, including Amgen and Bristol-Myers Squibb, to advance its testing capabilities and expand its diagnostic applications. Biocartis is committed to developing four to five new diagnostic applications each year, further enhancing its impact in the molecular diagnostics field.
MCENTIRE DAVIS ARCHITECTS, PLLC is a Suffolk, VA-based company in the Business Services sector.
Innovation and tradition share equally deep roots at SCARPA, which today remains a family owned company with its headquarters and performance footwear manufacturing facilities in the same regions of northern Italy where it got its start in 1938.
Xmultiple is a global manufacturer of connectivity products supporting twisted pair wiring communications, networking, RF/Microwave, test and measurement, broadcast,, medical, military and industrial applications. XMULTIPLE is a leader in the marketplace
iPacesetters powers growth through audience and customer engagement. By creating a centralized, unified, transactional database combined with performance-based call centers you interact with your audience across a variety of touch points, in real time.